Cargando…

Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosis

As the burden of neurodegenerative diseases increases, time-limited clinic encounters do not allow quantification of complex neurological functions. Patient-collected digital biomarkers may remedy this, if they provide reliable information. However, psychometric properties of digital tools remain la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pham, Linh, Harris, Thomas, Varosanec, Mihael, Morgan, Vanessa, Kosa, Peter, Bielekova, Bibiana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904910/ https://www.ncbi.nlm.nih.gov/pubmed/33627777 http://dx.doi.org/10.1038/s41746-021-00401-y

Ejemplares similares

Confounder-adjusted MRI-based predictors of multiple sclerosis disability
por: Kim, Yujin, et al.
Publicado: (2022)

Assessment of Smartphone-Based Spiral Tracing in Multiple Sclerosis Reveals Intra-Individual Reproducibility as a Major Determinant of the Clinical Utility of the Digital Test
por: Messan, Komi S., et al.
Publicado: (2022)

Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms
por: Kosa, Peter, et al.
Publicado: (2022)

Machine learning-optimized Combinatorial MRI scale (COMRISv2) correlates highly with cognitive and physical disability scales in Multiple Sclerosis patients
por: Kelly, Erin, et al.
Publicado: (2022)

Smartphone Level Test Measures Disability in Several Neurological Domains for Patients With Multiple Sclerosis
por: Boukhvalova, Alexandra K., et al.
Publicado: (2019)

Enhancing the clinical value of serum neurofilament light chain measurement
por: Kosa, Peter, et al.
Publicado: (2022)

Symbol Digit Modalities Test Variant in a Smartphone App for Persons With Multiple Sclerosis: Validation Study
por: van Oirschot, Pim, et al.
Publicado: (2020)

Remote administration of the symbol digit modalities test to individuals with multiple sclerosis is reliable: A short report
por: Eilam-Stock, Tehila, et al.
Publicado: (2021)

Identifying and Quantifying Neurological Disability via Smartphone
por: Boukhvalova, Alexandra K., et al.
Publicado: (2018)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis Through Immunophenotyping
por: Hannikainen, Paavali A., et al.
Publicado: (2020)

The Multiple Sclerosis Functional Composite and Symbol Digit Modalities Test as outcome measures in pediatric multiple sclerosis
por: Brenton, J. Nicholas, et al.
Publicado: (2019)

Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
por: Benedict, Ralph HB, et al.
Publicado: (2017)

Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis
por: Tanigawa, Makoto, et al.
Publicado: (2017)

NeurEx: digitalized neurological examination offers a novel high‐resolution disability scale
por: Kosa, Peter, et al.
Publicado: (2018)

Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis
por: Strober, Lauren, et al.
Publicado: (2018)

Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes
por: Natrajan, Muktha S., et al.
Publicado: (2015)

Biomarkers in Multiple Sclerosis
por: Martin, Roland, et al.
Publicado: (2006)

Functional MRI activation in white matter during the Symbol Digit Modalities Test
por: Gawryluk, Jodie R., et al.
Publicado: (2014)

Sensorimotor integration assessment by the Symbol-Digit modalities test in patients with Parkinson’s disease
por: Alamri, Yassar, et al.
Publicado: (2019)

Establishing the consistency of a voice recognition symbol digit modalities test analogue
por: Wishart, Margaret, et al.
Publicado: (2023)

1820. Efficacy of Pulse-Taper Corticosteroid Adjunctive Therapy for Refractory Non-HIV Cryptococcal Meningoencephalitis
por: Anjum, Seher, et al.
Publicado: (2019)

Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
por: Komori, Mika, et al.
Publicado: (2016)

Current Status and Future Opportunities in Modeling Clinical Characteristics of Multiple Sclerosis
por: Liu, Joshua, et al.
Publicado: (2022)

A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities Test
por: Middleton, Rod M, et al.
Publicado: (2020)

Computerized Symbol Digit Modalities Test in a Swiss Pediatric Cohort Part 1: Validation
por: Hochstrasser, Céline, et al.
Publicado: (2021)

Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
por: Zhang, Yinan, et al.
Publicado: (2020)

New Multiple Sclerosis Disease Severity Scale Predicts Future Accumulation of Disability
por: Weideman, Ann Marie, et al.
Publicado: (2017)

Computerized Symbol Digit Modalities Test in a Swiss Pediatric Cohort – Part 2: Clinical Implementation
por: Klein, Marie-Noëlle, et al.
Publicado: (2021)

Normative Data for the Symbol Digit Modalities Test in Older White Australians and Americans, African-Americans, and Hispanic/Latinos
por: Ryan, Joanne, et al.
Publicado: (2020)

Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders
por: Marrie, Ruth Ann, et al.
Publicado: (2020)

Quantifications of CSF Apoptotic Bodies Do Not Provide Clinical Value in Multiple Sclerosis
por: Masvekar, Ruturaj, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory Activity
por: Masvekar, Ruturaj, et al.
Publicado: (2021)

Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment
por: Kosa, Peter, et al.
Publicado: (2016)

Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis
por: Lin, Yen Chih, et al.
Publicado: (2015)

Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments
por: Weideman, Ann Marie, et al.
Publicado: (2017)

Effects of Mobile Identity on Smartphone Symbolic Use: An Attachment Theory Perspective
por: Lou, Jie, et al.
Publicado: (2022)

Diagnostic accuracy and reliability of smartphone captured radiologic images communicated via WhatsApp®
por: Ntja, Unathi, et al.
Publicado: (2022)

Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course
por: Castro, Kamilah, et al.
Publicado: (2019)

Validity and reliability of hallux valgus angle measurement on smartphone digital photographs
por: Cakar, Albert, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dd1rqa6i1vuic0p67t6mt439bd